Track topics on Twitter Track topics that are important to you
The FDA issued a safety alert warning health care providers that since 2016, five patients who were treated with liquid-filled intragastric balloons for obesity died unexpectedly.Four of these reported deaths involved patients treated with the Orbera Intragastric Balloon System (Apollo Endo Surgery) and one involved a patient treated with the ReShape Integrated Dual Balloon System (ReShape Medical).
Original Article: FDA safety alert: Five deaths after intragastric balloon insertionsNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...